OXI Share Price

Open 0.04 Change Price %
High 0.04 1 Day 0.00 0.00
Low 0.04 1 Week 0.00 0.00
Close 0.04 1 Month -0.01 -20.00
Volume 48000 1 Year -0.56 -93.33
52 Week High 0.55
52 Week Low 0.04
OXI Important Levels
Resistance 2 0.04
Resistance 1 0.04
Pivot 0.04
Support 1 0.04
Support 2 0.04
EPA France Most Active Stocks
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
AF 11.60 -4.13%
AF 11.60 -4.13%
AF 11.60 -4.13%
AF 11.60 -4.13%
GSZ 17.56 3.97%
More..
EPA France Top Gainers Stocks
MLFCI 0.26 62.50%
MLATV 4.15 20.29%
APAM 33.78 15.72%
APAM 33.78 15.72%
DEXB 17.47 13.89%
DEXB 17.47 13.89%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
More..
EPA France Top Losers Stocks
MLIML 0.44 -38.03%
ALALO 0.07 -12.50%
ALADM 2.54 -12.11%
ALBUD 4.61 -10.31%
MLPAC 2.21 -8.30%
ALAST 6.71 -7.70%
MLZAM 1.65 -6.78%
GBT 76.35 -5.86%
GBT 76.35 -5.86%
GBT 76.35 -5.86%
More..

Oxis International Inc (EPA: OXI)

OXI Technical Analysis 5
As on 27th Jul 2017 OXI Share Price closed @ 0.04 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.19 & Strong Sell for SHORT-TERM with Stoploss of 0.06 we also expect STOCK to react on Following IMPORTANT LEVELS.
OXI Target for July
1st Target up-side 0.06
2nd Target up-side 0.07
3rd Target up-side 0.08
1st Target down-side 0.02
2nd Target down-side 0.01
3rd Target down-side N/A
OXI Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.oxis.com
OXI Address
OXI
468 North Camden Drive
2nd Floor
Beverly Hills, CA 90210
United States
Phone: 310-860-5184
OXI Latest News
Form 8-K OXIS INTERNATIONAL INC For: Jul 17   StreetInsider.com   - 25th Jul 17
OXIS International, Inc. (OTCMKTS:OXIS) Might Be Looking For A Buyout   Insider Financial   - 28th Jun 17
OXIS International, Inc. (OTCMKTS:OXIS) Acquires Company, Attains New Board ...   Street Register   - 26th Jun 17
Here's What The Latest OXIS International Inc (OTCMKTS:OXIS) Announcement Means   Insider Financial   - 24th Mar 17
Tiny Tampa biotech files for public offering   Tampa Bay Business Journal   - 25th Aug 16
OXIS International, Inc. (OXIS) Could Hold The Key To Curing Cancer   Smarter Analyst   - 14th Jul 16
Oxis Chairman And CEO Tells Shareholders Biotech Company Making 'Substantial ...   PR Newswire (press release)   - 02nd Feb 16
Oxis Eliminates Debt In Restructuring Deal, Will Move Forward With Phase 1 ...   PR Newswire (press release)   - 11th Jan 16
What Happened to OXIS International, Inc. (OTCMKTS:OXIS)   MicroCap Daily   - 05th May 15
OXIS Biotech Issues Letter to Shareholders   PR Newswire (press release)   - 24th Feb 15
Interactive Technical Analysis Chart Oxis International Inc ( OXI EPA France )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Oxis International Inc
OXI Business Profile
Oxis International, Inc. engages in the research, development, and sale of pharmaceutical products for the treatment of oxidative stress and inflammation. Its finished product and finished product candidates include therapeutic nutraceutical products, cosmeceutical products, functionals foods, and functional beverages. The company also provides proprietary compounds and formulations to biotech and pharmaceutical companies as drug candidates; EGT, a dietary supplement; and ErgoFlex, dietary supplement for the treatment of joint pain and restricted mobility. In addition, it offers personal care products, including skin care and cosmetic products; and veterinary products for companion animals, livestock, and performance animals, such as race horses. The company owns a range of trademarks, including ErgoFlex, Ergo-Plex, ERGOLD, Ergo-Max, Ergo-Pur, V[eye]tamin, and Immortal Energy, as well as a non-EGT related trademark Palosein. Oxis International, Inc. was founded in 1965 and is based in Beverly Hills, California.